Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1996
06/06/1996CA2205577A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/06/1996CA2204902A1 Phosphocholine drug derivatives
06/06/1996CA2204000A1 Enantioselective preparation of pharmaceutically active sulfoxides by bioreduction
06/06/1996CA2203999A1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation
06/06/1996CA2180745A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
06/06/1996CA2164375A1 Heterocyclic amides
06/05/1996EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands
06/05/1996EP0714908A2 New 17-(3-imino-2-alkyl-propenyl)-5beta,14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
06/05/1996EP0714907A1 Oligoribonucleotides with amide backbone
06/05/1996EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors
06/05/1996EP0714897A1 Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity
06/05/1996EP0714896A1 Indol derivatives useful for the treatment of migraine, composition and utilization
06/05/1996EP0714895A1 Pyrrole derivatives
06/05/1996EP0714894A1 3-(1,2,3,6-tetrahydro-(1-alkylenearyl)-4-pyridinyl)- and 3-(1-alkylenearyl)-4-piperidinyl-1h-indoles: new 5-HT1f agonists
06/05/1996EP0714883A1 Aryloxypropanolamine beta 3 adrenergic agonists
06/05/1996EP0714880A1 Bis(methylidene)-phenylene-derivatives
06/05/1996EP0714663A2 Potentiation of drug response by a serotonin 1A receptor antagonist
06/05/1996EP0714661A1 Process for the preparation of tablets containing molsidomine
06/05/1996EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles
06/05/1996EP0714659A2 Indole derivatives in the treatment of emesis
06/05/1996EP0714658A1 Apoptosis inducer
06/05/1996EP0714449A1 Oligonucleotide modulation of protein kinase c
06/05/1996EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells
06/05/1996EP0714436A1 Oligonucleotides with activity against human immunodeficiency virus
06/05/1996EP0714418A1 Cosmetic melanins
06/05/1996EP0714411A1 Bioadhesive starches and process for their preparation
06/05/1996EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
06/05/1996EP0714397A1 Phenethylamine compounds
06/05/1996EP0714396A1 Vasocontrictive dihydrobenzopyran derivatives
06/05/1996EP0714395A1 Vasoconstrictive substituted dihydropyranopyridines
06/05/1996EP0714394A1 Antipsychotic method
06/05/1996EP0714393A1 Thiazoles as antiviral
06/05/1996EP0714392A1 Heterocycles useful as neurokinin antagonists
06/05/1996EP0714391A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists
06/05/1996EP0714390A1 Indole derivatives as 5-alpha-reductase-1-inhibitors
06/05/1996EP0714389A1 Amide and urea derivatives as 5ht1d receptor antagonists
06/05/1996EP0714388A1 Vasoconstrictive substituted aryloxyalkyl diamines
06/05/1996EP0714387A1 New bis-naphthalimides for the treatment of cancer
06/05/1996EP0714386A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
06/05/1996EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
06/05/1996EP0714304A1 Therapeutic system for treating psoriasis
06/05/1996EP0714303A1 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
06/05/1996EP0714301A1 Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments
06/05/1996EP0714300A1 Methods for modulating the human sexual response
06/05/1996EP0714299A1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
06/05/1996EP0714298A1 Photosensitizers
06/05/1996EP0714297A1 Novel 1,2-dithiin antiinfective agents
06/05/1996EP0714296A1 Flavonoid and biflavonoid derivatives, their pharmaceutical compositions, their anxiolytic activity
06/05/1996EP0714295A1 Fibrinogen receptor antagonists
06/05/1996EP0714294A1 Pharmaceutical compositions comprising metal complexes
06/05/1996EP0714293A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates
06/05/1996EP0714291A1 Lupane triterpenoid derivatives
06/05/1996EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
06/05/1996EP0714284A1 Use of oligosaccharides for the prevention and treatment of tissue ageing
06/05/1996EP0633780B1 Use of phenothiazine derivatives for treating ischaemia and/or hypoxia
06/05/1996EP0569383B1 LOW-MOLECULAR SULPHATED POLY-$g(b)-2,6-FRUCTOFURANOSANES AND THEIR USE IN THE TREATMENT OF DEGENERATIVE ARTICULAR AILMENTS
06/05/1996EP0555229B1 Accumulation of amino acids and peptides into liposomes
06/05/1996EP0460169B1 New chroman and thiochroman derivatives
06/05/1996EP0450039B1 Dihydro-1,2 oxo-2 quinoxaline derivates, their preparation and their application in therapeutics
06/05/1996DE4442999A1 Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten A pharmaceutical composition comprising an active loratidine metabolite
06/05/1996DE4442987A1 Kationische Biopolymere Cationic biopolymers
06/05/1996DE4442975A1 Agent contg. inulin for treating diabetes
06/05/1996DE4442766A1 Agent for treating arterial disorders and prostate complaints
06/05/1996DE4442561A1 Use of sucking pastilles contg. dimethicone
06/05/1996DE19501022C1 Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung Transdermal therapeutic system for administration of (S) -3-methyl-5- (1-methyl-2-pyrrolidenyl) isoxazole or a pharmaceutically acceptable salt thereof and process for its preparation
06/05/1996CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy
06/05/1996CN1124027A Ureido derivatives of naphthalenephosphonic acids and process for their preparation
06/05/1996CN1124026A Thioindole pyperidinyl derivatives used as antalgics
06/05/1996CN1124012A Arylating medicaments
06/05/1996CN1124006A Cholesterol lowering drink mix compositions
06/05/1996CN1123793A Non-reducing oligosaccharide and its production and use
06/05/1996CN1123664A Veterinary injection and its production
06/05/1996CN1123663A Composition for curing angicardiopathy and its production and usage
06/05/1996CN1123662A Special chicken-disease injection and its production
06/05/1996CN1123661A Zhonghua Lixing injection for dysentery and its production
06/05/1996CN1031942C Process for preparing steroids containing spiro ring use as pharmaceutical
06/05/1996CN1031940C Process for preparing substituted pyrrole compounds
06/05/1996CN1031939C Preparing process for brufen by molecular rearrangement under catalysis
06/04/1996US5523492 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
06/04/1996US5523490 Antitumor agents
06/04/1996US5523475 2-nitro-3-hydroxybenzoic acids as enzyme inhibitors of 3-hydroxyanthranilate oxygenase active in producing the neurotoxin, quinolinic acid
06/04/1996US5523464 Bone disorders
06/04/1996US5523461 Stabilization of a prostanoic acid compound
06/04/1996US5523457 Used for preventing or treating skin disorders like acne, psoriasis, damage for irradiation; antitumor agent
06/04/1996US5523455 Prepared using a naphthylhydrazine chemical intermediate
06/04/1996US5523415 Bactericides
06/04/1996US5523407 Quinoline derivatives, their production and use as ACAT inhibitors
06/04/1996US5523406 2-substituted tertiary carbinol derivatives of 1,5-iminosugars
06/04/1996US5523403 Tropone-substituted phenyloxazolidinone antibacterial agents
06/04/1996US5523389 Inhibitors of human immunodeficiency virus
06/04/1996US5523324 Composition
06/04/1996US5523323 Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence
06/04/1996US5523322 Method for inhibiting blood-platelet aggregration with β-naphthoquinone compounds
06/04/1996US5523321 Prostacyclins, their analogs or prostaglandins and thromboxane antagonists for treatment of thrombotic and thromboembolic syndromes
06/04/1996US5523320 For treatment of leukemia
06/04/1996US5523319 Compounds of the benzo-heterocycle family
06/04/1996US5523318 Pyrrolidino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
06/04/1996US5523317 Administering imidazole derivative
06/04/1996US5523315 N-(hydroxyethyl)butanediamide derivatives
06/04/1996US5523314 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease